Literature DB >> 17418234

Modulation of the antigenic peptide transporter TAP by recombinant antibodies binding to the last five residues of TAP1.

Gabriele Plewnia1, Katrin Schulze, Carola Hunte, Robert Tampé, Joachim Koch.   

Abstract

The transporter associated with antigen processing (TAP) plays a pivotal role in the major histocompatibility complex (MHC) class I mediated immune response against infected or malignantly transformed cells. It belongs to the ATP-binding cassette (ABC) superfamily and consists of TAP1 (ABCB2) and TAP2 (ABCB3), each of which possesses a transmembrane and a nucleotide-binding domain (NBD). Here we describe the generation of recombinant Fv and Fab antibody fragments to human TAP from a hybridoma cell line expressing the TAP1-specific monoclonal antibody mAb148.3. The epitope of the antibody was mapped to the very last five C-terminal amino acid residues of TAP1 on solid-supported peptide arrays. The recombinant antibody fragments were heterologously expressed in Escherichia coli and purified to homogeneity from periplasmic extracts by affinity chromatography. The monoclonal and recombinant antibodies bind with nanomolar affinity to the last five C-terminal amino acid residues of TAP1 as demonstrated by ELISA and surface plasmon resonance. Strikingly, the recombinant antibody fragments confer thermal stability to the heterodimeric TAP complex. At the same time TAP is arrested in a peptide transport incompetent conformation, although ATP and peptide binding to TAP are not affected. Based on our results we suggest that the C terminus of TAP1 modulates TAP function presumably as part of the dimer interface of the NBDs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418234     DOI: 10.1016/j.jmb.2007.02.102

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.

Authors:  Marvin M van Luijn; Martine E D Chamuleau; Maaike E Ressing; Emmanuel J Wiertz; Suzanne Ostrand-Rosenberg; Yuri Souwer; Adri Zevenbergen; Gert J Ossenkoppele; Arjan A van de Loosdrecht; S Marieke van Ham
Journal:  Cancer Immunol Immunother       Date:  2010-09-05       Impact factor: 6.968

2.  A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells.

Authors:  Janina Binici; Jessica Hartmann; Julia Herrmann; Christine Schreiber; Steffen Beyer; Günnur Güler; Vitali Vogel; Franz Tumulka; Rupert Abele; Werner Mäntele; Joachim Koch
Journal:  J Biol Chem       Date:  2013-10-16       Impact factor: 5.157

3.  Dynamics of major histocompatibility complex class I association with the human peptide-loading complex.

Authors:  Michaela S Panter; Ankur Jain; Ralf M Leonhardt; Taekjip Ha; Peter Cresswell
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

4.  Characterisation of mouse monoclonal antibodies against rhesus macaque killer immunoglobulin-like receptors KIR3D.

Authors:  Meike Hermes; Sandra Weil; Ariane Groth; Ralf Dressel; Joachim Koch; Lutz Walter
Journal:  Immunogenetics       Date:  2012-08-15       Impact factor: 2.846

5.  Viral immune evasins impact antigen presentation by allele-specific trapping of MHC I at the peptide-loading complex.

Authors:  Sunesh Sethumadhavan; Marie Barth; Robbert M Spaapen; Carla Schmidt; Simon Trowitzsch; Robert Tampé
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

6.  Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.

Authors:  Maria Trott; Svenja Weiβ; Sascha Antoni; Joachim Koch; Hagen von Briesen; Michael Hust; Ursula Dietrich
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

7.  Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.

Authors:  Oliver Ringel; Karsten Müller; Joachim Koch; Boris Brill; Timo Wolf; Christoph Stephan; Vincent Vieillard; Patrice Debré; Ursula Dietrich
Journal:  AIDS Res Hum Retroviruses       Date:  2018-01-25       Impact factor: 2.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.